相关实验视频

Updated: Jun 28, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

关于费城样B细胞急性淋巴细胞白血病的整合性见解:遗传和分子景观

Stacey Chuang¹, Alexandra Chu¹, Rodrigo Hurtado¹

¹The International Circle of Genetic Studies Project, Stony Brook Chapter, Stony Brook, NY 11794, USA.

Diagnostics (Basel, Switzerland)

|February 13, 2025

概括

费城样染色体急性淋巴细胞白血病 (Ph-like ALL) 是一种具有挑战性的B-ALL亚型,预后不佳,抗化学药性. 研究正在探索向治疗和干细胞移植,以改善这种侵袭性白血病的结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

费城样染色体急性淋巴细胞白血病 (Ph-like ALL) 是B细胞急性淋巴细胞白血病的一个独特亚型.
在2016年被世界卫生组织认可,Ph类ALL呈现出明显较其他ALL亚型的预后较差,其5年生存率仅为41%.

研究的目的:

审查目前关于Ph类ALL的研究结果.
专注于这种白血病亚型的分子景观和临床影响.

主要方法:

关于Ph类ALL的当前研究的文献综述.
分析分子变化及其对临床结果的影响.

主要成果:

类似PH的ALL的特点是诱导治疗后的化学抵抗和高最低残留疾病 (MRD) 水平.
高复发率与这种亚型有关.
目前正在进行的临床试验正在研究氨酸激酶抑制剂 (TKI) 和全源造血细胞移植 (allo-HCT).

结论:

类似PH的ALL需要新的治疗策略,因为它具有侵略性和对标准治疗的抵抗性.
包括TKIs在内的向疗法和allo-HCT是正在进行的研究的关键领域,旨在改善患者的生存率和治疗结果.

关键词:

B-ALL,所有的人.像PH这样的B-ALL 细胞遗传学细胞遗传学

更多相关视频

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...